COVID-19 vaccines and kidney disease

Patients with kidney diseases should be prioritized for COVID-19 vaccination and the available data suggest that replication-defective viral-vectored vaccines and mRNA vaccines are safe to use. As vaccine responses are likely to be lower in patients with kidney diseases than in the general populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Windpessl, Martin, Bruchfeld, Annette, Anders, Hans-Joachim, Kramer, Holly, Waldman, Meryl, Renia, Laurent, Ng, Lisa F. P., Xing, Zhou, Kronbichler, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869766/
https://www.ncbi.nlm.nih.gov/pubmed/33558753
http://dx.doi.org/10.1038/s41581-021-00406-6
Descripción
Sumario:Patients with kidney diseases should be prioritized for COVID-19 vaccination and the available data suggest that replication-defective viral-vectored vaccines and mRNA vaccines are safe to use. As vaccine responses are likely to be lower in patients with kidney diseases than in the general population, highly potent vaccines should be preferred.

Ejemplares similares